PUBLIKATIONEN

SUCCESS A und die zwei aktuell rekrutierenden Studien SUCCESS B und SUCCESS C stehen in der Nachfolge der großen und erfolgreichen ADEBAR Studie. Diese Kontinuität in der Therapie des Mamma Karzinoms ermöglicht  unserer Studiengruppe vielfältige Fragestellungen an einem großen Patientenkollektiv, mit einem bereits vor Jahren vorausschauend breit angelegtem Spektrum von wissenschaftlichen Daten, auf hohem Niveau zu erforschen.

Jährlich werden von den Mitgliedern unserer Studiengruppe eine große Zahl von Publikationen veröffentlicht und weltweit sehr viele Vorträge gehalten.
Diese Seite ermöglicht Ihnen einen kleinen Einblick in die aktuellen wissenschaftlichen Veröffentlichungen die aus den Daten der ADEBAR und SUCCESS Studien hervorgehen.
Bitte beachten Sie jedoch, daß bei allen Publikationen die gesamten Rechte bei den Urhebern liegen und die Ergebnisse sowie deren grafische Aufarbeitung keinesfalls ohne Zustimmung verwendet werden darf.

Jahr 2014
Internet
Thema
Publikation
Poster
Presentation
37nd Annual San Antonio Breast Cancer Symposium San Antonio Breast Cancer Symposium
www.sabcs.org/
Prevalence of circulating tumor cells (CTCs) after five years of zoledronate treatment in the adjuvant SUCCESS-A study   PDF  
    Prognostic relevance of Circulating Tumor Cells across different molecular subgroupsin the adjuvant SUCCESS-A Study   PDF  
    Detection of EMT, anoikis and stem cell markers in metastatic breast cancer patients under different lines of treatment   PDF  
Journal of the
National Cancer Institute
Homepage JNCI Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients   PDF  
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando San Antonio Breast Cancer Symposium
www.asco.org/
A Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Early Breast Cancer   PDF  
    DETECT III/IV - two combined clinical trials based on the phenotype of circulating tumor cells (CTCs)   PDF  
    A Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Early Breast Cancer     PDF
Jahr 2013
Internet
Thema
Publikation
Poster
Presentation
36nd Annual San Antonio Breast Cancer Symposium San Antonio Breast Cancer Symposium
www.sabcs.org/
EORTC 90091-10093 BIG 1-12 The Treat CTC trial – a new approach targeting circulating tumor cells (CTC) in early breast cancer (EBC)   PDF  
    A Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Early Breast Cancer   PDF  
    Discordance of the ER- and HER2-Status on Disseminated Tumor Cells Compared to the Primary Tumor in Patients With Early Breast Cancer   PDF  
    The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC)   PDF  
           
33. Jahrestagung der Deutschen Gesellschaft für Senologie – München  

Neue Studienkonzepte
Success

    PDF
    DETECT III     PDF
    4ever     PDF
    Senopedia Tools     PDF
           
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando San Antonio Breast Cancer Symposium
www.asco.org/
BioMarQ – a novel approach to automated HER2-analysis of circulating tumor cells (CTCs)   PDF  
  Evaluation of prevalence, number and temporal changes of circulating tumor cells as assessed after 2 and 5 years of follow-up in patients with early breast cancer in SUCCESS A study   PDF  
  Prognostic value of HER2 on breast cancer survival   PDF  
  Persistence of HER2-overexpression on circulating tumor cells (CTC) in patients after systemic treatment for HER2-positive breast cancer – Follow up results of the German SUCCESS B trial   PDF  
Jahr 2012
Internet
Thema
Publikation
Poster
Presentation
35nd Annual San Antonio Breast Cancer Symposium DETECT III ‐ A multicenter, randomized, phase III study to compare standard therapy alone...   PDF  
  Detection and characterization of circulating tumour cells in blood and disseminated tumour cells...   PDF  
  Circulating Tumor Cells (CTC) may Express HER2/neu in Patients With Early HER2/neu Negative Breast Cancer...   PDF  
  Prognostic Value of Relative Change in Tumor Marker CA 27.29 in Early Stage Breast Cancer...   PDF  
  Prognostic factors in young breast cancer patients over time...   PDF  
         
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando San Antonio Breast Cancer Symposium
www.asco.org/
HER2 expression on circulating tumor cells (CTC) in patients with early HER2-positive breast cancer:   PDF  
    Chemotherapy-induced amenorrhea in premenopausal breast cancer patients...   PDF  
    Correlation of BMI with tumor stage in early breast cancer patients...   PDF  
    Correlation of high body mass index and circulating tumor cell positivity in patients with early-stage breast cancer   PDF  
    Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel vs. FEC120...   PDF  
           
Jahr 2011
Internet
Thema
Publikation
Poster
Presentation
34nd Annual San Antonio Breast Cancer Symposium Sequential Treatment with
Epirubicin/Cyclophosphamide,
Followed by Docetaxel vs. FEC120 ...
  PDF  
  DETECT III - A multicenter, randomized, phase III study...   PDF  
  Evaluation of the prevalence and prognostic significance of VEGF165b...   PDF  
  Influence of the Progesterone Receptor on the Prognosis...   PDF  
  Correlation of two analytical methods for circulating...   PDF  
  Anti-Müllerian hormone (AMH) levels in...   PDF  
  Quantitative and immunohistochemical detection of breast...   PDF  
         
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando Prognostic value of CA27.29 trend...   PDF  
  Final Multivariate Analysis of Obesity and Disease...     PDF
  Prognostic relevance of circulating tumor cells (CTCs)...   PDF  
  Interim analysis of toxicity evaluating the role of an anthracycline free...   PDF  
Jahr 2010
Internet
Thema
Publikation
Poster
Presentation
33nd Annual San Antonio Breast Cancer Symposium Circulating tumor cells (CTC) in peripheral blood...   PDF  
  Prognostic Relevance of Circulating Tumor Cells...     PDF
  Multivariate Analysis of Obesity and Disease Free Survival...     PDF
  The prognostic relevance of serum CA 27.29 level...   PDF  
  Tumor Characteristics and Prognostic Factors in Nodal...    
         
 
Journal Onkologie 03/2010
Lifestyle und
Mammakarzinom
 
Journal Onkologie 03/2010 Journal Onkologie
www.journalonko.de
Neue Studienkonzepte am Beispiel
Mammakarzinom: Die SUCCESS C-Studie
PDF    
           
           
Jahr 2009
Internet
Thema
Poster
Presentation
 
Gemeinsame Tagung der Bayerische Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und österreichische Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) - Wien
Wertigkeit des Tumormarkes CA27-29
 
32nd Annual San Antonio Breast Cancer Symposium
Sequential Treatment with Epirubicin...
 
Evaluation of CA27-29 as...
 
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando
Effects of Granulocyte-colony...
   
Persistance of circulating tumor cells...
 
EuropeanCanCerOrganisation
Effects of G-CSF on circulating...
 
   
7th International Symposium on Minimal Residual Cancer
Dose dependent effects of G-CSF...
 
 
Jahr 2008
Internet
Poster
Presentation
 
31nd Annual San Antonio Breast Cancer Symposium
CA 27.29 as a tumour marker...
   
Toxicity analysis of a phase III study...
 
         
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando
Prognostic relevance of circulating tumorcells in
peripheral blood...
   
 
Jahr 2007
Internet
Poster
Presentation
 
30nd Annual San Antonio Breast Cancer Symposium
Final toxicity analysis of...